about
Degradation of the disease-associated prion protein by a serine protease from lichensInsights into the management of emerging infections: regulating variant Creutzfeldt-Jakob disease transfusion risk in the UK and the USTransmission of prionsTransmissible Spongiform Encephalopathies Affecting HumansA clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New GuineaGenetic susceptibility, evolution and the kuru epidemicKuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type miceUpdated projections of future vCJD deaths in the UKTissue classification for the epidemiological assessment of surgical transmission of sporadic Creutzfeldt-Jakob disease. A proposal on hypothetical risk levelsInsights into Mechanisms of Chronic NeurodegenerationSmall is the new big: An overview of newer supraglottic airways for childrenAn overview of human prion diseasesEffective gene therapy in a mouse model of prion diseasesEfficient uptake and dissemination of scrapie prion protein by astrocytes and fibroblasts from adult hamster brainAmyloid-β and proinflammatory cytokines utilize a prion protein-dependent pathway to activate NADPH oxidase and induce cofilin-actin rods in hippocampal neuronsSporadic--but not variant--Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1.Implications for Creutzfeldt-Jakob disease (CJD) in dentistry: a review of current knowledge.Cleanability of dental instruments--implications of residual protein and risks from Creutzfeldt-Jakob disease.Human prion diseases: surgical lessons learned from iatrogenic prion transmissionHuman prion diseases in the Netherlands (1998-2009): clinical, genetic and molecular aspects.Clinical diagnosis and differential diagnosis of CJD and vCJD. With special emphasis on laboratory tests.Neuroradiology of human prion diseases, diagnosis and differential diagnosis.Risk assessment of transmission of sporadic Creutzfeldt-Jakob disease in endodontic practice in absence of adequate prion inactivationCathepsin D SNP associated with increased risk of variant Creutzfeldt-Jakob disease.Ultraviolet-ozone treatment reduces levels of disease-associated prion protein and prion infectivity.The intriguing prion disorders.Brains from non-Alzheimer's individuals containing amyloid deposits accelerate Aβ deposition in vivoQuantitative detection and biological propagation of scrapie seeding activity in vitro facilitate use of prions as model pathogens for disinfectionVariant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public healthDefining sporadic Creutzfeldt-Jakob disease strains and their transmission properties.The epidemiological, clinical, and laboratory features of sporadic Creutzfeldt-Jakob disease patients in China: surveillance data from 2006 to 2010PrPTSE distribution in a primate model of variant, sporadic, and iatrogenic Creutzfeldt-Jakob disease.Prions in the urine of patients with variant Creutzfeldt-Jakob disease.Inactivation of prions by acidic sodium dodecyl sulfateClinical implications of bovine spongiform encephalopathy.Impact of leucocyte depletion and prion reduction filters on TSE blood borne transmission.Molecular pathology of human prion disease.Tau, prions and Aβ: the triad of neurodegeneration.Review: contribution of transgenic models to understanding human prion disease.Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies.
P2860
Q21135451-3C3D1EA7-FCD7-4F6C-9883-41F41E1BDF3EQ24288772-A87A0078-A415-455C-A080-3CBC1211AD5FQ24540228-9972F0F0-7B7A-4F50-A9F7-4721C0A60BE6Q24549130-0FB7421B-7005-4696-8735-C8D6CA92CBDDQ24642582-0B22BADA-427F-4698-96BD-143EAFA57661Q24645692-C3DF37F4-02EA-4715-B12D-24C1B75EBAF6Q24651920-F91926CA-7FEC-4412-ADAB-5B3D070371C1Q24799671-D4B2258C-42EF-4B30-AEE2-506701910012Q24800374-C2BE6175-B8CA-4228-BDB1-CF8ED20B5433Q26771732-3E082E51-0913-44E8-BC88-B958B5152172Q26772094-27913E70-45B5-47F8-8BAA-80226D9F92C8Q27007967-F5104156-8130-497A-ABF7-02006287F484Q27300832-CA20268D-139D-4526-B0F5-826CB04FDA9FQ27320015-243D49E7-B790-4347-AD44-A4515087F6C4Q27335309-6D530CF2-6015-40F0-834D-6C10679CBCC4Q28363814-0E7D65B9-FFCC-4150-B904-C7C0DB768719Q30228914-54A9DF53-35B3-401C-BFDF-044009BA737CQ30229334-15337D2E-6E3C-4C7A-B989-C35E5D37E61AQ30249207-C4F4C120-74A2-4C6E-9A9A-B212A924804EQ30467870-DD4E015C-DA8D-4AF9-A7E7-D092ADAE657AQ30698122-3D31426D-09C6-4066-889F-8BA687413C5EQ31155802-3B8F538B-B720-469A-AD63-F8583D1058A4Q33312361-CA11C15D-34CF-4CD5-82FF-9C1FD060AF81Q33329713-4D49FF7A-8D45-4960-9A08-D5C97DF33064Q33478741-8EA3AB43-A463-4A0B-B644-749B5C2337D2Q33581653-76B7787B-D369-471A-AF16-16DD1683F9BDQ33715557-DE8F1B47-8F0E-4F2B-BF11-893484860257Q33925227-4E15FF75-0E75-4A59-A53D-A54C44C2D619Q33956087-66A499FF-878F-4BB7-98CC-B8622EE04801Q33977675-5883A341-B5A1-4E32-8866-A456F6FC38BFQ34014523-DEA334EC-840A-42D3-91A0-501CF64AB0FEQ34123943-6F1DA324-0BD5-49F2-90B8-8695927B8F7EQ34173236-66A7C434-198D-4AC6-B8C5-A2A8347FF21CQ34232938-BAF5D9DA-089C-4F90-A8DD-80DC403C1B0BQ34255643-A4F9ECB6-618F-4CC2-8C70-BA8D265F92D7Q34364427-1CCB07E4-FFC2-4B7C-B29D-C24453E00130Q34462913-C83E28D0-E160-4F33-8F64-95EAF7258BA7Q34463061-FDA244E9-1774-4838-9DD4-80CEF83AD4CBQ34474868-74205817-8BF7-4E4A-A687-2C81E0B58C5CQ34489473-0E209881-9152-4CAF-928B-921E10F7661A
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Iatrogenic Creutzfeldt-Jakob disease at the millennium.
@ast
Iatrogenic Creutzfeldt-Jakob disease at the millennium.
@en
type
label
Iatrogenic Creutzfeldt-Jakob disease at the millennium.
@ast
Iatrogenic Creutzfeldt-Jakob disease at the millennium.
@en
prefLabel
Iatrogenic Creutzfeldt-Jakob disease at the millennium.
@ast
Iatrogenic Creutzfeldt-Jakob disease at the millennium.
@en
P2093
P356
P1433
P1476
Iatrogenic Creutzfeldt-Jakob disease at the millennium
@en
P2093
A Fletcher
J H d'Aignaux
J P Brandel
L B Schonberger
L Cervenáková
N R Cashman
P304
P356
10.1212/WNL.55.8.1075
P407
P577
2000-10-01T00:00:00Z